FGFR2 and metastatic malignant neoplasm in the lymph nodes: A meta-analysis published in 2019 concluded that high FGFR2 protein expression in GC was associated with worse outcomes, greater depth of invasion, higher rates of lymph node metastasis, and more advanced disease stage [28].